Yıl: 2023 Cilt: 86 Sayı: 2 Sayfa Aralığı: 152 - 158 Metin Dili: İngilizce DOI: 10.26650/IUITFD.1210739 İndeks Tarihi: 10-05-2023

HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?

Öz:
Objective: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a multifactorial disease in which the sinus and nasal mucosa are affected. We investigated the relationship between the genetic polymorphism of MMP9 (rs17576) and TIMP1 (rs48498) and serum levels, and we wanted to investigate the effect of MMP9 and TIMP1 genotypes on Vitamin serum levels in CRSwNP with and without Aspirin-Exacerbated Respiratory Disease (AERD). Materials and Methods: This study consisted of 99 patients with CRSwNP with AERD and CRSwNP without AERD. The RTPCR method and ELISA were used in this study. ELISA was used for MMP9 and TIMP1 serum levels and Vitamin D levels. Results: Serum levels of MMP9 were markedly higher in AG genotype than GG genotype in CRSwNP with AERD. Serum levels of MMP9 were statistically higher in carrying of A (+) allele in CRSwNP with AERD than in not carrying of A (+) allele. In addition, serum levels of Vitamin D were discovered significantly lower in TIMP1 CT genotype in comparison to CC and TT genotypes in all of CRSwNP. Conclusion: The rising of MMP9 serum levels may be a marker of chronic inflammation or they may be a significant factor in the resistance to diseases. This study may lead to a further understanding of disease severity in CRSwNP with AERD.
Anahtar Kelime:

MMP 9 VE TIMP 1 GENETİK VARYANTLARI VE VİTAMİN D NAZAL POLİPOZİSLİ KRONİK SİNÜZİTTE NASIL ETKİLİDİR?

Öz:
Amaç: Nazal polipli kronik rinosinüzit sinüs ve nazal mukozanın etkilendiği multifaktöriyel bir hastalıktır. MMP9 (rs17576) ve TIMP1 (rs 4898) genetik polimorfizmleri ile serum düzeyi arasındaki ilişki ve MMP9 ve TIMP1 genotipleri ve Vitamin D arasındaki bağlantının gösterilmesini araştırdık. Gereç ve Yöntem: Bu çalışma, aspirinle alevlenen solunum hastalığı olan veya olmayan nazal polipozisli kronik rinosinüzitli 99 hastadan oluşmaktadır. RT-PCR ve ELISA metodu kullanılmıştır. MMP9, TIMP1 ve Vitamin D serum seviyeleri için ELISA metodu kullanılmıştır. Bulgular: Aspirinle alevlenen solunum hastalığı eşlik eden nazal polipozisli kronik sinüzit hastalarında MMP9 serum seviyesi, AG genotipli hastalarda GG genotipli hastalara kıyasla daha yüksek seviyededir. Aynı zamanda bu hasta grubunda MMP9 serum seviyesi, A (+) alleli taşıyan grupta A (+) alleli taşımayan gruba göre daha yüksek seviyededir. Buna ek olarak TIMP1 CT genotipine sahip olanlar, TIMP1 CC ve TT genotipleri ile kıyaslandığında Vitamin D serum seviyesinin anlamlı olarak düşük olduğu gösterilmiştir. Sonuç: MMP9 serum düzeylerinin yükselmesi, kronik inflamasyonun bir belirteci olabilir veya hastalık direncinde önemli bir faktör olabilir. Bu çalışma, aspirinle alevlenen solunum hastalığı olan nazal polipozisli kronik rinosinüzitte hastalık şiddetinin daha iyi anlaşılmasına yardımcı olabilir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol 2012;23(Suppl):1-298.
  • 2. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347(19):1493-9. [CrossRef]
  • 3. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure, and function. Biochim Biophys Acta 2000;1477(1-2):267-83. [CrossRef]
  • 4. Wang LF, Lee CH, Chien CY, Chen JY, Chiang FY, Tai CF. Serum 25-hydroxyvitamin D levels are lower in chronic rhinosinusitis with nasal polyposis and are correlated with disease severity in Taiwanese patients. Am J Rhinol Allergy 2013;27(6):e162-5. [CrossRef]
  • 5. Mulligan JK, White DR, Wang EW, Sansoni SR, Moses H, Yawn RJ. Vitamin D3 deficiency increases sinus mucosa dendritic cells in pediatric chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 2012;147(4):773-81. [CrossRef]
  • 6. Thomas M, Yawn B, Price D, Lund V, Mullol J, Fokkens W. et al. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 – a summary. Primary Care Respiratory Journal 2008;17(2):79-89. [CrossRef]
  • 7. Watelet JB, Bachert C, Claeys C, Cauwenberge PV. Matrix metalloproteinases MMP-7, MMP-9, and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy 2004;59(1):54-60. [CrossRef]
  • 8. Stevens WW, Peters AT, Hirsch AG, Nordberg CM, Schwartz BS, Mercer DG et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 2017;5(4):1061-70. [CrossRef]
  • 9. Wang LF, Chien CY, Tai CF, Kuo WR, Hsi E, Hank Juo SH. Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis. BMC Med Genet 2010;11:85. [CrossRef]
  • 10. Guerra G, Testa D, Salzano AF, Tafuri D, Hay E, Schettino A. Expression of matrix metalloproteinases and their tissue inhibitors in chronic rhinosinusitis with nasal polyps: etiopathogenesis and recurrence. Ear Nose Throat J 2021;100(5_Suppl):597S-605S [CrossRef]
  • 11. Yeo NK, Eom DW, Oh MY, Lim HW, Song YJ. Expression of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 1 in nonrecurrent vs recurrent nasal polyps. Ann Allergy Asthma Immunol 2013;111(3):205-10. [CrossRef]
  • 12. Mudd PA, Katial RK, Alam R, Hohensee S, Ramakrishnan V, Kingdom TT. Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis. Ann Allergy Asthma Immunol 2011;107(4):353-9. [CrossRef]
  • 13. Lai CY, Chang WS, Hsieh YH, Hsu CM, Tsai CW, Chen AC, et al. Association of tissue inhibitor of metalloproteinase-1 genotypes with lung cancer risk in Taiwan. Anticancer Res 2016;36(1):155-60.
  • 14. Chang WS, Liu LC, Hsiao CL, Su CH, Wang HC, Ji HX et al. The contributions of the tissue inhibitor of metalloproteinase-1 genotypes to triple-negative breast cancer risk. Biomedicine (Taipei) 2016;6(1):4. [CrossRef]
  • 15. Wang HX, Yang QD, Liu BQ, Zhang L, Ma MM, Hu ZY, et al. TIMP-1 polymorphisms in a Chinese Han population with intracerebral hemorrhage. Int J Neurosci 2014;124(1):61-7. [CrossRef]
  • 16. Chotchaeva ZC, Shcheglova EV, Boeva OI, Hait GY, Magazinyuk TP, Rogova SS, et al. Matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases type 1 serum concentrations and genetic polymorphism in senile aortic stenosis. Adv Gerontol 2015;28(2):222-7. [CrossRef]
  • 17. Vira H, Pradhan V, Umare V, Chaudhary A., Rajadhyksha A., Nadkar M. et al.Role of polymorphisms in MMP-9 and TIMP-1 as biomarkers for susceptibility to systemic lupus erythematosus patients. Birromark Med 2019;13(1):33-43. [CrossRef]
  • 18. Hashemian F, Sadegh S, Jahanshahi J, Rabiei MAS, Hashemian F. Effects of Vitamin D supplementation on recurrence of nasal polyposis after endoscopic sinus surgery. Iran J. Otorhinolaryngol 2020;32(108):21-28
  • 19. Alnori H, Alassaf FA, Alfahad M, Qazzaz ME, Jasim M, Abed MN. Vitamin D and Immunoglobulin E status in allergic rhinitis patients compared to healthy people J Med Life 2020:13(4):463-8. [CrossRef]
  • 20. Wang LF, Tai CF, Chien CY, Chiang FY, Chen JYF. Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis. Kaohsiung J Med Sci 2015;31(5):235-40. [CrossRef]
APA Bozacı M, Ertugrul B, KASARCİ G, Çomoğlu Ş, Aydemir L, Keles Turel M, Gelincik A, Cakmakoglu B (2023). HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. , 152 - 158. 10.26650/IUITFD.1210739
Chicago Bozacı Meltem,Ertugrul Baris,KASARCİ GOKSU,Çomoğlu Şenol,Aydemir Levent,Keles Turel Meryem Nesil,Gelincik Aslı,Cakmakoglu Bedia HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. (2023): 152 - 158. 10.26650/IUITFD.1210739
MLA Bozacı Meltem,Ertugrul Baris,KASARCİ GOKSU,Çomoğlu Şenol,Aydemir Levent,Keles Turel Meryem Nesil,Gelincik Aslı,Cakmakoglu Bedia HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. , 2023, ss.152 - 158. 10.26650/IUITFD.1210739
AMA Bozacı M,Ertugrul B,KASARCİ G,Çomoğlu Ş,Aydemir L,Keles Turel M,Gelincik A,Cakmakoglu B HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. . 2023; 152 - 158. 10.26650/IUITFD.1210739
Vancouver Bozacı M,Ertugrul B,KASARCİ G,Çomoğlu Ş,Aydemir L,Keles Turel M,Gelincik A,Cakmakoglu B HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. . 2023; 152 - 158. 10.26650/IUITFD.1210739
IEEE Bozacı M,Ertugrul B,KASARCİ G,Çomoğlu Ş,Aydemir L,Keles Turel M,Gelincik A,Cakmakoglu B "HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?." , ss.152 - 158, 2023. 10.26650/IUITFD.1210739
ISNAD Bozacı, Meltem vd. "HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?". (2023), 152-158. https://doi.org/10.26650/IUITFD.1210739
APA Bozacı M, Ertugrul B, KASARCİ G, Çomoğlu Ş, Aydemir L, Keles Turel M, Gelincik A, Cakmakoglu B (2023). HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. İstanbul Tıp Fakültesi Dergisi, 86(2), 152 - 158. 10.26650/IUITFD.1210739
Chicago Bozacı Meltem,Ertugrul Baris,KASARCİ GOKSU,Çomoğlu Şenol,Aydemir Levent,Keles Turel Meryem Nesil,Gelincik Aslı,Cakmakoglu Bedia HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. İstanbul Tıp Fakültesi Dergisi 86, no.2 (2023): 152 - 158. 10.26650/IUITFD.1210739
MLA Bozacı Meltem,Ertugrul Baris,KASARCİ GOKSU,Çomoğlu Şenol,Aydemir Levent,Keles Turel Meryem Nesil,Gelincik Aslı,Cakmakoglu Bedia HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. İstanbul Tıp Fakültesi Dergisi, vol.86, no.2, 2023, ss.152 - 158. 10.26650/IUITFD.1210739
AMA Bozacı M,Ertugrul B,KASARCİ G,Çomoğlu Ş,Aydemir L,Keles Turel M,Gelincik A,Cakmakoglu B HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. İstanbul Tıp Fakültesi Dergisi. 2023; 86(2): 152 - 158. 10.26650/IUITFD.1210739
Vancouver Bozacı M,Ertugrul B,KASARCİ G,Çomoğlu Ş,Aydemir L,Keles Turel M,Gelincik A,Cakmakoglu B HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?. İstanbul Tıp Fakültesi Dergisi. 2023; 86(2): 152 - 158. 10.26650/IUITFD.1210739
IEEE Bozacı M,Ertugrul B,KASARCİ G,Çomoğlu Ş,Aydemir L,Keles Turel M,Gelincik A,Cakmakoglu B "HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?." İstanbul Tıp Fakültesi Dergisi, 86, ss.152 - 158, 2023. 10.26650/IUITFD.1210739
ISNAD Bozacı, Meltem vd. "HOW DO THE GENETIC VARIANTS OF MMP 9 AND TIMP 1 AND VITAMIN D AFFECT CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS?". İstanbul Tıp Fakültesi Dergisi 86/2 (2023), 152-158. https://doi.org/10.26650/IUITFD.1210739